New Company Secretary and Chief Operating Officer Appointed; CS Resignation Accepted

Board approved three leadership changes, all effective 30th September 2026.

Wed 30 Sep 2026

Resignation Effective Date

30th September 2026

New Company Secretary & Compliance Officer

Mr. Ashwani Singh Bisht

New COO Appointment

Mr. Arvind Gannimitta

COO Experience

Ph.D. in Pharmaceuticals with over 26 years in pharmaceutical operations

Company Secretary Experience

Qualified CS with over 12 years of professional experience

What the board decided

The board meeting held on 30th September 2026 (10:30 a.m. to 11:45 a.m., at the registered office) approved three personnel changes.

• Resignation of Ms. Shivali Aggarwal as Company Secretary & Compliance Officer, accepted with effect from 30th September 2026. Her letter dated 11th August 2026 cited a personal situation requiring her full-time presence at her place. An earlier board outcome dated 11th August 2026 had said the resignation would be effective on or before 12th October 2026; it has now been made effective from 30th September 2026.
• Appointment of Mr. Ashwani Singh Bisht as Company Secretary & Compliance Officer, designated as Key Managerial Personnel, with effect from 30th September 2026, on whole-time employment terms.
• Appointment of Mr. Arvind Gannimitta as Chief Operating Officer, classified as Senior Management Personnel, with effect from 30th September 2026, on whole-time employment terms.

Backgrounds as stated

• Mr. Bisht is a qualified Company Secretary and a member of the Institute of Company Secretaries of India (Membership No. A72076), with over 12 years of professional experience including more than 5 years in corporate secretarial and compliance functions. He has handled secretarial and corporate law matters for listed and unlisted companies, has exposure to merchant banking activities, and has served as an academician.
• Mr. Gannimitta holds a Ph.D. in Pharmaceuticals and has over 26 years of experience in pharmaceutical operations, including managing pharmaceutical manufacturing and operational functions and regulatory requirements.

How to read this

The Company Secretary and Compliance Officer role is the mandatory link between a listed company and the stock exchanges, so filling it immediately on the outgoing officer's last day avoids any gap in compliance responsibility. The COO appointment adds a senior operations head with a pharmaceutical manufacturing background, which is relevant for a company in injectables and formulations.

No financial terms, remuneration figures or business impact numbers form part of this decision. The disclosure is a management-change intimation rather than an event affecting revenue or assets.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.